Preventive Healthcare Technologies and Services Market Outlook 2028

  • The global preventive healthcare technologies and services market was valued at US$ 217.09 Mn in 2020
  • It is estimated to expand at a CAGR of 13% from 2021 to 2028
  • The global preventive healthcare technologies and services market is expected to reach the value of US$ 557.47 Mn by the end of 2028

Analysts’ Viewpoint on Preventive Healthcare Technologies and Services Market Scenario

An increasing number of pharmacists and hospitals are investing in computer systems & software products to ensure robust supply of life-saving drugs & medical devices amid the ongoing COVID-19 pandemic. However, high installation and maintenance cost of healthcare IT & deficient patient engagement activities tend to demotivate physicians & pharmacists to adopt these preventive healthcare technologies. Hence, stakeholders in the preventive healthcare technologies and services market should increase awareness about the advantages of healthcare IT, which enables long-term cost efficiency and compensates for current high installation costs. The proliferation of digital technologies is expected to augment the growth of the preventive healthcare technologies and services market.

Preventive Healthcare Technologies and Services Help Reduce Cost Burden

The rise in demand for technological upgrade of healthcare systems and self-monitoring devices is likely to reduce the cost burden, thus contributing to the growth of the global preventive healthcare technologies and services market. The global preventive healthcare technologies and services market is driven by favorable government policies for increase in social awareness about vaccination through governmental & non-governmental organizations and adoption of healthcare information technology (IT).

Request a sample to get extensive insights into the Preventive Healthcare Technologies and Services Market

Good Manufacturing Practices Instrumental in COVID-19 Vaccine Packaging and Delivery

Companies in the preventive healthcare technologies and services market have come under great scrutiny amid ongoing COVID-19 pandemic. The unprecedented demand for flu vaccines has compelled manufacturing units, medical packaging companies, and vaccine delivery centers to streamline processes with the help of healthcare IT.

Good manufacturing practices (GMP) continue to be followed during the entire production process and delivery of life-altering drugs & medical devices. The trend of on-demand products and services is growing prominent in the preventive healthcare technologies and services market. Technologies such as machine learning (ML) are anticipated to gain traction with increasing the adoption of automated prescription systems and computerized provider order entry systems.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Proliferation of Digital Systems Holds Potentials for Patient Engagement with Healthcare IT

Constructive government policies that provide favorable environment for awareness & initiatives for prophylaxis and proliferation of healthcare information technologies are major drivers of the global preventive healthcare technologies and services market. Reduced healthcare cost burden due to penetration of the healthcare information technology and surge in demand for self-monitoring devices are key factors anticipated to propel the global market

However, high installation and maintenance costs have hampered the penetration of preventive technologies in developing economies such as India, Philippines, Bangladesh, and Sri Lanka. The lack of patient engagement activities has demotivated physicians and pharmacists to adopt healthcare IT. However, the COVID-19 pandemic has led to an influx of digital systems, which are expected to increase acceptance for healthcare IT in developing economies. Trends such as telehealth and eHealth mobile apps are expected to augment the market for healthcare IT.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Preventive Healthcare Technologies and Services Market

Commercialization of Preventive Healthcare Technologies Pivotal in Developing Regions

North America is predicted to be the largest and fastest growing region in the preventive healthcare technologies and services market during the assessment period. Presence of major healthcare companies, supportive reimbursement policies, international hub of information technology, and high awareness about preventive healthcare technologies are major factors boosting the expansion of the market in North America.

Technologies such as electronic prescribing, clinical decision supptort sysem, and automated prescription, and formulation & dispensing are still at the nascent stage and expected to drive the market after commercialization. Hence, other regions such as Asia Pacific, Latin America, and Middle East & Africa hold lucrative revenue opportunities with the current market penetration estimated to be low. In all means, healthcare stakeholders in these regions should increase awareness about the advantages of preventive healthcare technologies and services since long-term benefits of these systems have the potential to offset initial installation costs.

Automated Screening & Precision Medicine Generating Value-grab Opportunities for Stakeholders

Based on early detection & screening technologies, companies in the market are increasing R&D in automated screening technologies and personalized medicine. Personalized medicine was the largest segment of the global market in 2020 due to high investments in genomics research and proteomics. The automated screening segment is likely to expand at a high CAGR during the forecast period due to increasing number of telehealth kiosks by pharmacies & clinics coupled with a high demand for automated melanoma screening techniques.

Preventive Healthcare Technologies and Services Market: Overview

  • Preventive healthcare comprises measures taken for prevention of disease by predetermination of the disease or immunization
  • The diseases that are monitored or immunized vastly are cardiovascular diseases, chronic respiratory diseases, accidental complications, diabetes, and certain infectious diseases. In the modern era, preventive healthcare is attributed to technology that aids significant growth in its application range and efficiency.
  • A decade old revolution of information technology has also influenced the healthcare market and contributed to the growth of the global preventive healthcare technology and services market

Rise in Demand for Innovative Technologies: Major Driver

  • Constructive government policies that provide favorable environment for healthcare information technology and increase in awareness and initiatives for prophylaxis are the major drivers of the global preventive healthcare technologies and services market
  • Reduced healthcare cost burden due to penetration of healthcare information technology and surge in demand for self-monitoring devices are other key factors anticipated to propel the global market
  • However, high installation and maintenance costs have hampered the penetration of preventive technologies in the emerging markets. Deficient patient engagement activities have demotivated physicians and pharmacists to adopt the technology.

Preventive Healthcare Technologies and Services Market: Segmentation

  • The global preventive healthcare technologies & services market has been segmented based on early detection & screening technologies, prophylaxis technologies, advanced technologies to reduce errors, and chronic disease management technologies
  • In terms of early detection & screening technologies, the global marked has been classified into personalized medicine, automated screening techniques, and other automated screening techniques. Personalized medicine was the largest segment in 2020 due to increase in research on proteomics & genomics.

North America to Dominate Preventive Healthcare Technologies and Services Market

  • In terms of region, the global preventive healthcare technologies and services market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America is projected to dominate the global market during the forecast period, accounting for 39.70% share by 2028. The market in the region is anticipated to reach US$ 221.32 Mn by 2028.
  • North America is anticipated to be the largest and fastest growing market for preventive healthcare technologies and services from 2021 to 2028. Supportive reimbursement policies, international hub of information technology, high awareness about preventive healthcare technologies, and presence of major players are the major factors boosting the growth of the market in North America.
  • Technologies such as electronic prescribing, clinical decision support system, and automated prescription, formulation, and dispensing are at a nascent stage and are expected to drive the market after commercialization. Hence, other regions such as Asia Pacific, Latin America, and MEA are likely to be potential markets in the near future, with the current market penetration estimated to be low.

Major Players

  • Key players operating in the global preventive healthcare technologies and services market are
    • Dilon Technologies, Inc.
    • Myraid Genetics, Inc.
    • Novx Systems, Inc.
    • U-Systems, Inc.
    • Viatronix, Inc.
    • Sanofi Pasteur MSD
    • Merck & Co.
    • GlaxoSmithKline plc
    • Lifecom, Inc.
    • Scripto LLC
    • Omnicell, Inc.
    • Alere
    • Healthways, Inc.
    • Omron Healthcare, Inc
    • Medtronic
  • Each of these players has been profiled in the preventive healthcare technologies and services market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Preventive Healthcare Technologies and Services Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 217.09 Mn

Market Forecast Value in 2028

US$ 557.47 Mn

Growth Rate (CAGR)

13%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Early Detection & Screening Technologies
    • Personalized Medicine
    • Automated Screening
    • Other Advanced Screening Tests
  • Prophylaxis Technologies
    • Flu Vaccines
    • Meningococcal Vaccines
    • Combined Tetanus-Diphtheria-Pertussis Vaccines
    • Human Papillomavirus Vaccine
    • Other New Vaccines
  • Advanced Technologies to Reduce Errors
    • Electronic Prescribing
    • Computerized Provider Order Entry Systems
    • Clinical Decision Support System
    • Automated Prescription, Formulation, and Dispensing
    • Smart Infusion Pumps
    • Smart Packaging
  • Advanced Technologies to Reduce Errors
    • Blood Pressure Monitors
    • Glucose Monitors
    • Cardiac Monitors
    • Asthma Monitors

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Preventive Healthcare Technologies and Services Market – Segmentation

TMR’s study on the global preventive healthcare technologies and services market includes information divided into four segments: early detection & screening technologies, prophylaxis technologies, advanced technologies to reduce errors, and chronic disease management technologies. Changing industry trends and other market dynamics associated with these segments of the global preventive healthcare technologies and services market are discussed in detail.

Early Detection & Screening Technologies
  • Personalized Medicine
  • Automated Screening
  • Other Advanced Screening Tests
Prophylaxis Technologies
  • Flu Vaccines
  • Meningococcal Vaccines
  • Combined Tetanus-Diphtheria-Pertussis Vaccines
  • Human Papillomavirus Vaccine
  • Other New Vaccines
Advanced Technologies to Reduce Errors
  • Electronic Prescribing
  • Computerized Provider Order Entry Systems
  • Clinical Decision Support System
  • Automated Prescription, Formulation, and Dispensing
  • Smart Infusion Pumps
  • Smart Packaging
Chronic Disease Management Technologies
  • Blood Pressure Monitors
  • Glucose Monitors
  • Cardiac Monitors
  • Asthma Monitors

Frequently Asked Questions

Preventive healthcare technologies and services market is expected to reach the value of US$ 557.47 Mn by the end of 2028

Preventive healthcare technologies and services market is estimated to expand at a CAGR of 13% from 2021 to 2028

Preventive healthcare technologies and services market is driven by increase in social awareness about vaccination through governmental & non-governmental organizations

North America accounted for the largest share of the global preventive healthcare technologies and services market

Key players in the global preventive healthcare technologies and services market include Dilon Technologies, Inc., Myraid Genetics, Inc., Noxx Systems, Inc., U-Systems, Inc., Viatronix, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Preventive Healthcare Technologies and Services Market

4. Market Overview

    4.1. Introduction

        4.1.1. Early Detection & Screening Technologies Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Key Mergers & Acquisitions

    5.3. Technological Advancements

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Early Detection & Screening Technologies

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028

        6.3.1. Personalized Medicine

        6.3.2. Automated Screening

        6.3.3. Other advanced screening tests

    6.4. Market Attractiveness Analysis, By Early Detection & Screening Technologies

7. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Prophylaxis Technologies

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028

        7.3.1. Influenza Vaccines

        7.3.2. Meningococcal Vaccines

        7.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines

        7.3.4. Human Papilloma Virus Vaccine

        7.3.5. Other new vaccines

    7.4. Market Attractiveness Analysis, By Prophylaxis Technologies

8. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Advance Technologies to Reduce Errors

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028

        8.3.1. Electronic Prescribing

        8.3.2. Computerized Provider Order Entry Systems

        8.3.3. Clinical Decision Support System

        8.3.4. Automated Prescription, Formulation, and Dispensing

        8.3.5. Smart Infusion Pumps

        8.3.6. Smart Packaging

    8.4. Market Attractiveness Analysis, By Advance Technologies to Reduce Errors

9. Global Preventive Healthcare Technologies and Services Market Analysis and Forecast, By Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, By Country/Region

10. North America Preventive Healthcare Technologies and Services Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017- 2028

        10.2.1. Personalized Medicine

        10.2.2. Automated Screening

        10.2.3. Other Advanced Screening Tests

    10.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028

        10.3.1. Influenza Vaccines

        10.3.2. Meningococcal Vaccines

        10.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines

        10.3.4. Human Papilloma Virus Vaccine

        10.3.5. Other new vaccines

    10.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028

        10.4.1. Electronic Prescribing

        10.4.2. Computerized Provider Order Entry Systems

        10.4.3. Clinical Decision Support System

        10.4.4. Automated Prescription, Formulation, and Dispensing

        10.4.5. Smart Infusion Pumps

        10.4.6. Smart Packaging

    10.5. Market Value Forecast, by Country, 2017–2028

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Early Detection & Screening Technologies

        10.6.2. By Prophylaxis Technologies

        10.6.3. By Advance Technologies to Reduce Errors

        10.6.4. By Country

11. Europe Preventive Healthcare Technologies and Services Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028

        11.2.1. Personalized Medicine

        11.2.2. Automated Screening

        11.2.3. Other Advanced Screening Tests

    11.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028

        11.3.1. Influenza Vaccines

        11.3.2. Meningococcal Vaccines

        11.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines

        11.3.4. Human Papilloma Virus Vaccine

        11.3.5. Other new vaccines

    11.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028

        11.4.1. Electronic Prescribing

        11.4.2. Computerized Provider Order Entry Systems

        11.4.3. Clinical Decision Support System

        11.4.4. Automated Prescription, Formulation, and Dispensing

        11.4.5. Smart Infusion Pumps

        11.4.6. Smart Packaging

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Early Detection & Screening Technologies

        11.6.2. By Prophylaxis Technologies

        11.6.3. By Advance Technologies to Reduce Errors

        11.6.4. By Country/Sub-region

12. Asia Pacific Preventive Healthcare Technologies and Services Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028

        12.2.1. Personalized Medicine

        12.2.2. Automated Screening

        12.2.3. Other Advanced Screening Tests

    12.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028

        12.3.1. Influenza Vaccines

        12.3.2. Meningococcal Vaccines

        12.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines

        12.3.4. Human Papilloma Virus Vaccine

        12.3.5. Other new vaccines

    12.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028

        12.4.1. Electronic Prescribing

        12.4.2. Computerized Provider Order Entry Systems

        12.4.3. Clinical Decision Support System

        12.4.4. Automated Prescription, Formulation, and Dispensing

        12.4.5. Smart Infusion Pumps

        12.4.6. Smart Packaging

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Early Detection & Screening Technologies

        12.6.2. By Prophylaxis Technologies

        12.6.3. By Advance Technologies to Reduce Errors

        12.6.4. By Country/Sub-region

13. Latin America Preventive Healthcare Technologies and Services Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028

        13.2.1. Personalized Medicine

        13.2.2. Automated Screening

        13.2.3. Other Advanced Screening Tests

    13.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028

        13.3.1. Influenza Vaccines

        13.3.2. Meningococcal Vaccines

        13.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines

        13.3.4. Human Papilloma Virus Vaccine

        13.3.5. Other new vaccines

    13.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028

        13.4.1. Electronic Prescribing

        13.4.2. Computerized Provider Order Entry Systems

        13.4.3. Clinical Decision Support System

        13.4.4. Automated Prescription, Formulation, and Dispensing

        13.4.5. Smart Infusion Pumps

        13.4.6. Smart Packaging

    13.5. Market Value  Forecast, by Country/Sub-region, 2017–2028

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Early Detection & Screening Technologies

        13.6.2. By Prophylaxis Technologies

        13.6.3. By Advance Technologies to Reduce Errors

        13.6.4. By Country/Sub-region

14. Middle East & Africa Preventive Healthcare Technologies and Services Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Early Detection & Screening Technologies, 2017–2028

        14.2.1. Personalized Medicine

        14.2.2. Automated Screening

        14.2.3. Other Advanced Screening Tests

    14.3. Market Value Forecast, by Prophylaxis Technologies, 2017–2028

        14.3.1. Influenza Vaccines

        14.3.2. Meningococcal Vaccines

        14.3.3. Combined Tetanus-Diphtheria-Pertussis Vaccines

        14.3.4. Human Papilloma Virus Vaccine

        14.3.5. Other new vaccines

    14.4. Market Value Forecast, by Advance Technologies to Reduce Errors, 2017–2028

        14.4.1. Electronic Prescribing

        14.4.2. Computerized Provider Order Entry Systems

        14.4.3. Clinical Decision Support System

        14.4.4. Automated Prescription, Formulation, and Dispensing

        14.4.5. Smart Infusion Pumps

        14.4.6. Smart Packaging

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2028

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Early Detection & Screening Technologies

        14.6.2. By Prophylaxis Technologies

        14.6.3. By Advance Technologies to Reduce Errors

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix

    15.2. Market Share Analysis, by Company, 2020

    15.3. Market Footprint Analysis

        15.3.1. By Region

        15.3.2. By Early Detection & Screening Technologies Type

    15.4. Competitive Business Strategies

    15.5. Company Profiles

        15.5.1. Alere

            15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.1.2. Product Portfolio

            15.5.1.3. SWOT Analysis

            15.5.1.4. Strategic Overview

        15.5.2. Dilon Technologies, Inc.

            15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.2.2. Product Portfolio

            15.5.2.3. SWOT Analysis

            15.5.2.4. Strategic Overview

        15.5.3. GlaxoSmithKline plc

            15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.3.2. Product Portfolio

            15.5.3.3. SWOT Analysis

            15.5.3.4. Strategic Overview

        15.5.4. Healthways, Inc.

            15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.4.2. Product Portfolio

            15.5.4.3. SWOT Analysis

            15.5.4.4. Strategic Overview

        15.5.5. Lifecom, Inc.

            15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.5.2. Product Portfolio

            15.5.5.3. SWOT Analysis

            15.5.5.4. Strategic Overview

        15.5.6. Medtronic.

            15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.6.2. Product Portfolio

            15.5.6.3. SWOT Analysis

            15.5.6.4. Strategic Overview

        15.5.7. Merck & Co.

            15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.7.2. Product Portfolio

            15.5.7.3. SWOT Analysis

            15.5.7.4. Strategic Overview

        15.5.8. Myraid Genetics

            15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.8.2. Product Portfolio

            15.5.8.3. SWOT Analysis

            15.5.8.4. Strategic Overview

        15.5.9. Novx Systems, Inc.

            15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.9.2. Product Portfolio

            15.5.9.3. SWOT Analysis

            15.5.9.4. Strategic Overview

        15.5.10. Omnicell, Inc.

            15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.10.2. Product Portfolio

            15.5.10.3. SWOT Analysis

            15.5.10.4. Strategic Overview

        15.5.11. Omron Healthcare, Inc.

            15.5.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.11.2. Product Portfolio

            15.5.11.3. SWOT Analysis

            15.5.11.4. Strategic Overview

        15.5.12. Sanofi Pasteur MSD

            15.5.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.12.2. Product Portfolio

            15.5.12.3. SWOT Analysis

            15.5.12.4. Strategic Overview

        15.5.13. Scripto LLC

            15.5.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.13.2. Product Portfolio

            15.5.13.3. SWOT Analysis

            15.5.13.4. Strategic Overview

        15.5.14. U-Systems, Inc.

            15.5.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.5.14.2. Product Portfolio

            15.5.14.3. SWOT Analysis

            15.5.14.4. Strategic Overview

List of Tables

Table 01: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028

Table 02: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Personalized Medicine, 2017–2028

Table 03: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 04: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028

Table 05: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028

Table 06: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Advance Technologies to Reduce Errors, 2017–2028

Table 07: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, by Region, 2017–2028

Table 08: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country, 2017–2028

Table 09: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028

Table 10: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028

Table 11: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 12: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028

Table 13: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028

Table 14: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Advance Technologies to Reduce Errors, 2017–2028

Table 15: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 16: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028

Table 17: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028

Table 18: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 19: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028

Table 20: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028

Table 21: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Advance Technologies to Reduce Errors, 2017–2028

Table 22: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 23: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, Early Detection & Screening Technologies, 2017–2028

Table 24: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028

Table 25: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 26: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028

Table 27: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028

Table 28: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028

Table 29: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 30: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, Early Detection & Screening Technologies, 2017–2028

Table 31: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028

Table 32: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 33: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028

Table 34: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028

Table 35: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Early Detection & Screening Technologies, 2017–2028

Table 36: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

Table 37: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Personalized Medicine, 2017–2028

Table 38: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 39: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Automated Screening, 2017–2028

Table 40: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Other Advanced Screening Tests, 2017–2028

Table 41: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, by Prophylaxis Technologies, 2017–2028

Table 42: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast, Early Detection & Screening Technologies, 2017–2028

List of Figures

Figure 01: Global Preventive Healthcare Technologies and Services Market Value (US$ Mn) Forecast, 2017–2028

Figure 02: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Early Detection & Screening Technologies, 2017 and 2028

Figure 03: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Personalized Medicine, 2017–2028

Figure 04 Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Screening, 2017–2028

Figure 05: Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2028

Figure 06: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028

Figure 07: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Flu Vaccines, 2017 and 2028

Figure 08: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Meningococcal Vaccines, 2017–2028

Figure 09: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Combined Tetanus-Diphtheria-Pertussis Vaccines, 2017–2028

Figure 10: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human Papilloma Virus Vaccine, 2017–2028

Figure 11: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others New Vaccine, 2017–2028

Figure 12: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Advance Technologies to Reduce Errors, 2017–2028

Figure 13: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Electronic Prescribing, 2018 - 2028

Figure 14: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Computerized Provider Order Entry Systems, 2017 and 2028

Figure 15: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinical Decision Support System, 2017–2028

Figure 16: Global Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Automated Prescription, Formulation, and Dispensing, 2017–2028

Figure 17: Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Smart Infusion Pumps, 2017–2028

Figure 18: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Smart Packaging, 2017-2028

Figure 19: Global Preventive Healthcare Early Detection & Screening Technologies, 2017-2028

Figure 20: Global Preventive Healthcare Technologies and Services Market Value Share Analysis, by Region, 2017 and 2026

Figure 21: Global Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Region

Figure 22: North America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 23: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Country, 2017 and 2028

Figure 24: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country, 2017–2028

Figure 25: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028

Figure 26: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2017–2028

Figure 27: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028

Figure 28: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028

Figure 29: North America Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028

Figure 30: North America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2018–2028

Figure 31: Europe Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 32: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028

Figure 33: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 34: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028

Figure 35: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2018–2028

Figure 36: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028

Figure 37: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028

Figure 38: Europe Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028

Figure 39: Europe Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2017–2028

Figure 40: Asia Pacific Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 41: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028

Figure 42: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 43: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028

Figure 44: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2017–2028

Figure 45: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028

Figure 46: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by , 2017–2028

Figure 47: Asia Pacific Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028

Figure 48: Asia Pacific Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2018–2028

Figure 49: Latin America Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 50: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028

Figure 51: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-region, 2017–2028

Figure 52: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028

Figure 53: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2018–2028

Figure 54: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028

Figure 55: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2017–2028

Figure 56: Latin America Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028

Figure 57: Latin America Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2018–2028

Figure 58: Middle East & Africa Preventive Healthcare Technologies and Services Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2028

Figure 59: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Country/Sub-region, 2017 and 2028

Figure 60: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Country/Sub-2018–2028

Figure 61: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Early Detection & Screening Technologies, 2017 and 2028

Figure 62: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Early Detection & Screening Technologies, 2018–2028

Figure 63: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Prophylaxis Technologies, 2017 and 2028

Figure 64: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Prophylaxis Technologies, 2018–2028

Figure 65: Middle East & Africa Preventive Healthcare Technologies and Services Market Value Share (%), by Advance Technologies to Reduce Errors, 2017 and 2028

Figure 66: Middle East & Africa Preventive Healthcare Technologies and Services Market Attractiveness Analysis, by Advance Technologies to Reduce Errors, 2017–2028

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Preventive Healthcare Technologies And Services Market